Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD45 and anti-Myosin parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit stem cells to infarcted myocardium. It is designed for the research of Myocardial infarction therapy.
There are currently no customer reviews or questions for Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG-IgG) (BSIG-122). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS